References
- Canadian Tobacco, Alcohol and Drugs (CTADS) Survey. 2018. Available from: https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2017-summary/2017-detailed-tables.html#t16.
- Cannabis Legalization and Regulation. Available from: https://www.justice.gc.ca/eng/cj-jp/cannabis/.
- Rotermann M. What has changed since cannabis was legalized? Health Rep. 2020;31(2):11–20.
- Allan GM, Ramji J, Perry D, et al. Simplified guideline for prescribing medical cannabinoids in primary care. Can Fam Physician. 2018;64(2):111–120.
- Amin MR, Ali DW. Pharmacology of medical cannabis. Adv Exp Med Biol. 2019;1162:151–165.
- Chakrabarty I, Sengupta D, Bhattacharya P, et al. Effect of cannabis extract on the uterine monoamine oxidase activity of normal and estradiol treated rats. Biochem Pharmacol. 1976;25(4):377–378.
- Dixit VP, Arya M, Lohiya NK. The effect of chronically administered cannabis extract on the female genital tract of mice and rats. Endokrinologie. 1975;66(3):365–368.
- Charavarty I, Sengupta D, Bhattacharyya P, et al. Effect of treatment with cannabis extract on the water and glycogen contents of the uterus in normal and estradiol-treated prepubertal rats. Toxicol Appl Pharmacol. 1975;34(3):513–516.
- Sauer MA, Rifka SM, Hawks RL, et al. Marijuana: interaction with the estrogen receptor. J Pharmacol Exp Ther. 1983;224(2):404–407.
- von Bueren AO, Schlumpf M, Lichtensteiger W. Tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells. Anticancer Res. 2008;28(1A):85–89.
- Rawitch AB, Schultz GS, Ebner KE, et al. Competition of delta 9-tetrahydrocannabinol with estrogen in rat uterine estrogen receptor binding. Science. 1977;197(4309):1189–1191.
- Okey AB, Bondy GP, Solomon J, et al. Is delta-9-tetrahydrocannabinol estrogenic? Science. 1977;195(4281):904–906.
- Smith RG, Besch NF, Besch PK, et al. Inhibition of gonadotropin by delta9-tetrahydrocannabinol:mediation by steroid receptors? Science. 1979;204(4390):325–327.
- Okey AB, Truant GS. Cannabis demasculinizes rats but is not estrogenic. Life Sci. 1975;17(7):1113–1117.
- ElSohly MA, Mehmedic Z, Foster S, et al. Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States. Biol Psychiatry. 2016;79(7):613–619.
- Gibson C, Huang A, Maguen S, et al. Cannabis use for menopause symptom management among midlife women Veterans. Proceedings of the 2020 Virtual Annual Meeting of the North American Menopause Society (NAMS); San Francisco VA Health Care System; University of California; 2020. 14.
- Bar-Lev Schleider L, Abuhasira R, Novack V. Medical cannabis: aligning use to evidence-based medicine approach. Br J Clin Pharmacol. 2018;84(11):2458–2462.
- McKeon R, Rittenberg E. Why are women using CBD products — and do they work? 2019. Available from: https://www.health.harvard.edu/blog/why-are-women-using-cbd-products-and-do-they-work-2019111818317#:∼:text=Sellers%20of%20these%20products%20make,cure%20acne%2C%20and%20calm%20rosacea.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
- Downes MJ, Brennan ML, Williams HC, et al. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6(12):e011458.
- Tufanaru C, Munn Z, Aromataris E, et al. Systematic reviews of effectiveness. Joanna Briggs Institute Reviewer's Manual; 2017. Available from https://reviewersmanual.joannabriggs.org/.
- Fantry LE, Zhan M, Taylor GH, et al. Age of menopause and menopausal symptoms in HIV-infected women. AIDS Patient Care STDs. 2005;19(11):703–711.
- Slavin M, Farmer S, Earleywine M. Expectancy mediated effects of marijuana on menopause symptoms. Addict Res Theory. 2016;24(4):322–329.
- Benedikt RA, Cristofaro P, Mendelson JH, et al. Effects of acute marijuana smoking in post-menopausal women. Psychopharmacology (Berl). 1986;90(1):14–17.
- McNair D, Lorr M, Droppelman L. Profile of mood states. San Diego (CA): Educational and Industrial Testing Service; 1971.
- Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric. 2020;23(5):426–446.
- Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604–606.
- Golezar S, Ramezani Tehrani F, Khazaei S, et al. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019;22(4):403–411.
- Tariq S, Anderson J, Burns F, et al. The menopause transition in women living with HIV: current evidence and future avenues of research. J Virus Erad. 2016;2(2):114–116.